| 注册
首页|期刊导航|中国医学创新|血塞通联合依达拉奉对老年缺血性脑卒中患者神经功能和血清hs-CRP、D-二聚体水平的影响

血塞通联合依达拉奉对老年缺血性脑卒中患者神经功能和血清hs-CRP、D-二聚体水平的影响

郭翠萍 付丽琴 叶锦华

中国医学创新2025,Vol.22Issue(13):36-40,5.
中国医学创新2025,Vol.22Issue(13):36-40,5.DOI:10.3969/j.issn.1674-4985.2025.13.008

血塞通联合依达拉奉对老年缺血性脑卒中患者神经功能和血清hs-CRP、D-二聚体水平的影响

Effects of Xuesaitong Combined with Edaravone on Neurological Function and Serum hs-CRP and D-dimer Levels in Elderly Patients with Cerebtral Ischemic Stroke

郭翠萍 1付丽琴 2叶锦华2

作者信息

  • 1. 樟树市人民医院药剂科 江西 樟树 331200
  • 2. 樟树市人民医院心内科 江西 樟树 331200
  • 折叠

摘要

Abstract

Objective:To investigate the application effect of Xuesaitong combined with Edaravone in elderly patients with cerebral ischemic stroke(CIS).Method:Seventy-four elderly CIS patients admitted to Zhangshu People's Hospital from January 2022 to September 2023 were selected as the study objects,and were randomly divided into observation group(n=37)and control group(n=37).Both groups received conventional symptomatic neurological treatment,on the basis of which the control group received Edaravone treatment,and the observation group received Xuesaitong combined with Edaravone treatment,and both groups received continuous treatment for 14 days.The clinical efficacy of the two groups was compared,the neurological function of the patients were assessed by the national institutes of health stroke scale(NIHSS),the serum levels of hypersensitive C reactive protein(hs-CRP)and D-dimer(D-D)were detected by immunoturbidimetry,and the occurrence of adverse reactions during treatment was recorded.Result:During the study period,2 patients in the observation group were lost to follow-up,and 2 patients in the control group withdrew from the study due to personal reasons and did not complete the treatment cycle,and 35 patients in the observation group and 35 patients in the control group were final.After treatment,the total effective rates of the observation group and the control group were 91.43%and 71.43%,respectively,the difference was statistically significant(P<0.05).After 7 and 14 days of treatment,the NIHSS score,serum hs-CRP and D-D levels in the observation group were lower than those before treatment and those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:Applying Xuesaitong combined with Edaravone in the treatment of elderly patients with CIS can promote neurological function recovery,reduce the levels of serum hs-CRP and D-D,and does not increase adverse reactions.

关键词

缺血性脑卒中/老年患者/血塞通/依达拉奉/神经功能/超敏C反应蛋白/D-二聚体

Key words

Cerebral ischemic stroke/Elderly patients/Xuesaitong/Edaravone/Neurological function/High-sensitivity C reactive protein/D-dimer

引用本文复制引用

郭翠萍,付丽琴,叶锦华..血塞通联合依达拉奉对老年缺血性脑卒中患者神经功能和血清hs-CRP、D-二聚体水平的影响[J].中国医学创新,2025,22(13):36-40,5.

中国医学创新

1674-4985

访问量2
|
下载量0
段落导航相关论文